European stock markets traded in a mixed fashion Wednesday, as traders digest stronger-than-expected German economic growth as well a swathe of corporate results. Bullish exports and solid construction activity helped the German economy to grow by a stronger-than-expected 0.3% in the final quarter of last year, a revision higher from an earlier estimate of 0.1% growth. On the flip side, AstraZeneca (NASDAQ:AZN) stock fell 1.4% after Reuters reported that the drugmaker has told the European Union it expects to deliver less than half the Covid-19 vaccines it was contracted to supply in the second quarter.
It’s a relatively quiet day ahead on the economic calendar, with German 2nd estimate GDP numbers the only major data release of the day.
Economic data from the Eurozone and the U.S will be in focus today. FED Chair Powell’s testimony may have the final say, however.